DUBLIN--(BUSINESS WIRE)--Aug 23, 2018--The "Endovascular Aneurysm Repair Market, Patient Numbers, by Stent Graft, Regions, End-User and Companies" report has been added to ResearchAndMarkets.com's offering.

Endovascular Aneurysm Repair Market is expected to surpass US$ 3.8 Billion by the end of the year 2024

Endovascular aneurysm repair (or endovascular aortic repair) (EVAR) is a type of endovascular surgery used to treat pathology of the aorta. In this medical procedure, Stent graft is placed inside an Aorta without removing any tissue from patients Aorta as it's required in open aortic surgery.

Endovascular Aneurysm Repair is more popular than open-abdominal surgery as its less invasive and patient recovery time is faster. In Endovascular Aneurysm Repair Stent graft is used in three types Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), Thoracoabdominal Aortic Aneurysm (TAAA). This report exclusively covers endovascular aneurysm repair via different products of a stent graft.

The main factors that reinforce stent graft market growth are increasing the prevalence of cardiac diseases & Hyper Tension, Growing Geriatric population, unhealthy lifestyle, alcohol consumption and smoking. High Medical Cost, Lack of reimbursement policies and increasing out of pocket expenditure can hinder the market growth of Endovascular Aneurysm Repair Market.

Key Topics Covered:

1. Executive Summary

2. Global Stent Graft (Endovascular Aneurysm Repair) Market & Patient Numbers

3. Market Share - Stent Graft

4. Stent Graft Market & Patient Numbers - Endovascular Surgery (Endovascular Aneurysm Repair)

5. Region (Market & Patient Numbers) - Abdominal Aortic Stent Graft

6. Region (Market & Patients) - Thoracic Aortic Stent Graft

7. Region (Market & Patients) - Thoracoabdominal Aortic Stent Graft

8. End-User - Global Stent Graft (Market & Patients)

9. Lombard Medical Technologies - Company Overview

10. Medtronic Inc. - Company Analysis

11. Endologix Inc. - Company Analysis

12. Terumo Corporation - Company Analysis

13. LeMaitre Vascular - Company Analysis

14. Growth Drivers

15. Challenges

For more information about this report visit https://www.researchandmarkets.com/research/grp4zz/global_3_8_bn?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005399/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Stents,Surgical Procedures



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/23/2018 08:44 AM/DISC: 08/23/2018 08:44 AM